Kolkata, 24 July 2025: In a significant stride towards decentralizing world-class cancer treatment, Medella Karkinos Oncology Institute, a part of Karkinos Healthcare and a leading technology-driven oncology platform, has announced the launch of cutting-edge cancer care facilities at its centre in Kamarhati, Agarpara, North 24 Parganas. This strategic expansion is aimed at offering affordable, high-quality cancer care to underserved districts such as Nadia, Hooghly, and North 24 Parganas.
With the sharp rise in cancer incidence in West Bengal—over 100,000 new cases annually, according to recent data—this move comes as a critical intervention in bridging the gap between urban and semi-urban healthcare access. The institute will now offer specialised clinics in Gastro, Breast Care, Head & Neck-Dental, Pain & Palliative, and Gyne-Oncology—bringing comprehensive care closer to home for thousands of patients.
“Our focus is on providing world-class, yet accessible cancer treatment to semi-urban and rural Bengal,” said Dr. Akther Jawade, Director East, Karkinos Healthcare. “Most of these advanced services were so far concentrated in Kolkata. This expansion ensures timely and life-saving intervention for patients who earlier had to travel far for treatment.”
The facility boasts state-of-the-art infrastructure, including Radiation Oncology with Halcyon machines, Medical Oncology, and Surgical Oncology under one roof. Additionally, it is empanelled with Swasthya Sathi, West Bengal’s flagship health insurance scheme—ensuring financial relief for economically vulnerable families.
Built as part of Karkinos Healthcare’s Distributed Cancer Care Network (DCCN), the institute is equipped with a 50-bed capacity, fully equipped ICU, advanced Operation Theatres, and an in-house team of expert onco-pathologists and technologists, supported by a global board of advisors.
Notably, Medella Karkinos also leverages next-generation molecular diagnostics and NGS technologies through its pan-India network of Karkinos labs—enabling precision-based, individualized cancer therapies tailored to a patient’s genetic profile.
“We’re not just offering treatment; we’re building a cancer care ecosystem—from community-level screenings to next-gen diagnostics and advanced therapy,” Dr. Jawade added. “This institute reflects our commitment to care without compromise, for every individual, regardless of geography or income.”
ABOUT MEDELLA KARKINOS ONCOLOGY INSTITUTE: Located at 87F, BT Road, Kamarhati, Agarpara, Kolkata 700058, Medella Karkinos Oncology Institute stands as a beacon of holistic cancer care in Bengal. It offers integrated services across prevention, early detection, diagnostics, treatment, and recovery—ensuring seamless, tech-enabled, and compassionate care.
ABOUT KARKINOS HEALTHCARE: A step-down subsidiary of Reliance Industries Limited, Karkinos Healthcare is a technology-powered oncology platform championing distributed, decentralised cancer care across India. Through its collaborations with top-tier medical and academic institutions globally, Karkinos ensures that no person is deprived of cancer care due to lack of access or affordability.
